Another Big Payout! Healthcare Company Declares Rs. 80/sh Dividend; Rs.260 Paid Last Year; Check Record Date

Procter & Gamble Health Limited (P&G Health), the maker of popular healthcare products like Polybion, Cosome, Evion, Neurobion, etc., has announced its latest financial results along with a major corporate action of an interim dividend payout for its investors.

P&G Health Dividend Announcement

In an exchange filing, Procter & Gamble Health Limited (P&G Health) announced a generous Rs.80 per share interim dividend for the financial year 2024-25. The company stated in its filing, "The Board of Directors has declared an interim dividend of Rs.80 per equity share for the financial year 2024-25. The record date to determine eligible shareholders for the dividend is February 21, 2025."

P&G Health's Dividend History

P&G Health has given consistent and substantial dividend payouts. In 2024 alone, the company declared three dividends. Last year in February, the company announced an interim dividend of Rs.50 per share, along with a special dividend of Rs.150 per share in the same month. A final dividend of Rs. 60 per share was declared in November 2024.

P&G Health Financial Results

P&G Health reported its financial results for the quarter ending December 31, 2024, which highlighted steady sales and impressive profit growth. As per the press release on BSE, the total sales of the company stood at Rs.304 crore, remaining flat compared to the same quarter last year. However, the Profit After Tax (PAT) surged 26% YoY, reaching Rs.91 crore. Adjusted for one-time items, operational PAT grew by 13% YoY, due to strong business efficiency.

P&G Health Share Performance

At the end of Friday's trading session, shares of P&G Health closed at Rs.5,220, down 1.66% for the day. Market volatility impacted the stock in the past week, with a 3.11% decline.
However, long-term investors have seen steady gains, as in 1 year, the shares grew by 2.28%.
And in the last 5 years, the stock appreciated up to 21.46%.

About P&G Health

P&G Health, formerly a part of Merck, was established in 1967 as one of Merck's Asian subsidiaries. As per the company website, the firm went public in 1981, making it the first Merck Group company to be listed. Operated in pharmaceuticals and chemicals until 2018, after which it became part of Procter & Gamble's healthcare portfolio. P&G Health has a strong brand presence, and it is a major player in India's healthcare and pharmaceutical sector.